Sequent Scientific - Recovery in API Business; Gross Margin Remains Below FY21
Sequent Scientific’s (SSL) 4QFY22 revenue at Rs3,837mn was broadly in line with our estimate. However, EBITDA and net profit declined by 8% QoQ and...
209 Views
J.B.Chemicals (JBCP IN): Partial Tender Offer by KKR
The Promoters of J.B. Chemicals & Pharma (JBCP IN)announced on 3rd July they had signed an SPA with KKR & Co Inc (KKR US) to sell up to 54%...
404 Views
Partial Tender Offer for Sequent Scientific
On 8th May, India's largest pure-play animal healthcare company Sequent Scientific (SEQ IN), announced that The Carlyle Group had entered into...
361 Views
Profit from India's Rapidly Growing Biotechnology Industry
Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...
4.9k Views
India's Budgets: 2006-2015. Key Charts, and Key questions
In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective: 2014 Actual...
371 Views